Sale!

PAFAH1B1 Gene Lissencephaly Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PAFAH1B1 gene plays a crucial role in neuronal migration during the early stages of brain development. Mutations in this gene are associated with Lissencephaly Type 1, a rare genetic disorder characterized by the smoothness of the brain’s surface, leading to severe intellectual disability and developmental delays. The genetic test for Lissencephaly Type 1, focusing on the PAFAH1B1 gene, is a critical tool for diagnosing this condition. It involves analyzing the DNA to identify mutations in the PAFAH1B1 gene that are indicative of Lissencephaly Type 1. This test is available at DNA Labs UAE, a leading facility for genetic testing in the United Arab Emirates. The cost of the test is 4400 AED, making it accessible for families seeking answers about this challenging condition. Early diagnosis through this genetic test can lead to better management and support for individuals affected by Lissencephaly Type 1.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PAFAH1B1 Gene Lissencephaly type 1 Genetic Test

Test Name: PAFAH1B1 Gene Lissencephaly type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PAFAH1B1 Gene Lissencephaly type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PAFAH1B1 Gene Lissencephaly type 1 NGS Genetic DNA Test gene PAFAH1B1

Test Details

The PAFAH1B1 gene, also known as LIS1 gene, is associated with a condition called lissencephaly type 1. Lissencephaly is a rare genetic disorder characterized by the absence or underdevelopment of brain folds (gyri) and a smooth brain surface. This condition typically leads to severe intellectual disability, developmental delays, seizures, and other neurological problems.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of specific genes or the entire genome. In the context of lissencephaly type 1, NGS genetic testing can be used to identify mutations or variations in the PAFAH1B1 gene that may be responsible for the condition.

By analyzing the genetic material, such as DNA, obtained from a patient’s blood or other tissue samples, NGS can identify specific changes or mutations in the PAFAH1B1 gene that may be associated with lissencephaly type 1. This information can help in confirming a diagnosis, understanding the underlying cause of the condition, and providing genetic counseling to affected individuals and their families.

It is important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare professional’s order. The results of the test should be interpreted by a geneticist or other qualified healthcare provider who can provide appropriate counseling and guidance based on the findings.

Test Name PAFAH1B1 Gene Lissencephaly type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PAFAH1B1 Gene Lissencephaly type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PAFAH1B1 Gene Lissencephaly type 1 NGS Genetic DNA Test gene PAFAH1B1
Test Details

The PAFAH1B1 gene, also known as LIS1 gene, is associated with a condition called lissencephaly type 1. Lissencephaly is a rare genetic disorder characterized by the absence or underdevelopment of brain folds (gyri) and a smooth brain surface. This condition typically leads to severe intellectual disability, developmental delays, seizures, and other neurological problems.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of specific genes or the entire genome. In the context of lissencephaly type 1, NGS genetic testing can be used to identify mutations or variations in the PAFAH1B1 gene that may be responsible for the condition.

By analyzing the genetic material, such as DNA, obtained from a patient’s blood or other tissue samples, NGS can identify specific changes or mutations in the PAFAH1B1 gene that may be associated with lissencephaly type 1. This information can help in confirming a diagnosis, understanding the underlying cause of the condition, and providing genetic counseling to affected individuals and their families.

It is important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare professional’s order. The results of the test should be interpreted by a geneticist or other qualified healthcare provider who can provide appropriate counseling and guidance based on the findings.